GALNS Antikörper (AA 236-263)
Kurzübersicht für GALNS Antikörper (AA 236-263) (ABIN7872630)
Target
Alle GALNS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 236-263
-
Verwendungszweck
- GALNS Antibody
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 236-263 from the human protein was used as the immunogen for the GALNS antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the GALNS antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the GALNS antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- GALNS (Galactosamine (N-Acetyl)-6-Sulfate Sulfatase (GALNS))
-
Andere Bezeichnung
- GALNS
-
Hintergrund
- This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq].
-
UniProt
- P34059
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-